Latest "Augme Technologies, Inc." News Stories

19:13 EDT 24th September 2018 | BioPortfolio

Here are the most relevant search results for "Augme Technologies, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Augme Technologies, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Augme Technologies, Inc. for you to read. Along with our medical data and news we also list Augme Technologies, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Augme Technologies, Inc. Companies for you to search.

Showing "Augme Technologies" News Articles 1–25 of 5,100+

Monday 24th September 2018

Kape Technologies (158355634KAPE) - Strong H1 performance

Edison Investment Research - Technology - Kape Technologies: With Kape’s transition to a consumer cybersecurity business essentially complete, investors can focus on the trends in its core business. The interim results highlighted big improvements in both margins and visibility. A doubling of subscribers helped drive a 178% y-o-y rise in underlying EBITDA. We leave our estimates unchanged bu...

Hamamatsu to Distribute Energetiq’s LDLS™ Products

Energetiq’s world-class manufacturing and service augmented by Hamamatsu’s global distribution. WOBURN, Mass. (PRWEB) September 24, 2018 Energetiq Technology, a world leader in high brightness light sources for advanced technology applications, is pleased to announce that starting on October 1, 2018 Hamamatsu will distribute the company’s Laser-Driven Light Sources around the globe. Hamamat...

Cook Medical Receives FDA Approval for First 5 mm Diameter SFA Drug-Eluting Stent

Cook Medical announced that a new 5 mm diameter version of Zilver® PTX® was approved by the FDA. It is the first 5 mm drug-eluting stent in the U.S. with lengths available up to 140 mm that is indicated to treat vessels as small as 4mm in diameter. The range of Zilver PTX stent diameters now available will address treatment of vessel sizes from 4–7 mm ...

Ping An Unveils AI Technology at International Maritime Silk Road Forum

Empowers Smart City and Healthcare HONG KONG and SHANGHAI, Sept. 24, 2018 /PRNewswire/ -- The second 21st Century Maritime Silk Road Forum on International Communication was held in Zhuhai in 19-21 September. Jean-Pierre Raffarin, former Prime Minister of France and Thomas J. Sargent, the 2011 Nobel Prize winner for Economics delivered keynote speeches at the main forum. As a leading compan...

Emergent BioSolutions Expands Manufacturing Capability with ABEC Dual Purpose Single-Use Microbial Fermentation / Mammalian Cell Culture Systems

ABEC’s Custom Single Run (CSR®) systems to enhance Emergent BioSolutions’ manufacturing productivity, flexibility and economies of scale ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced the shipment of

JEFF believe gene-editing technologies going to transform medical treatments for diverse diseases;current leaders in gene-editing are platform plays, reminiscent of where $ALNY was 2012-2013 $KITE $CELG were in 2015-2016 –current valuations for $NTLA $C

JEFF believe gene-editing technologies going to transform medical treatments for diverse diseases;current leaders in gene-editing are platform plays, reminiscent of where $ALNY was 2012-2013 $KITE $CELG were in 2015-2016 –current valuations for $NTLA

Cerveau Technologies Inc. Signs Research Agreement with Ionis Pharmaceuticals, Inc. for Novel Tau Imaging Agent

Cerveau Technologies, Inc. today announced a research collaboration agreement with Ionis Pharmaceuticals, Inc. for use of [F-18]MK-6240, an investigational imaging agent to be used in Positron Emission Tomography (PET) scans for assessing the status and progression of neurofibrillary tangles (NFTs) in the brain. NFTs made up of aggregated tau protein are a...

Bluestar Genomics Scientists Non-Invasively Detect Epigenomic Signatures of Early Pancreatic Cancer

In the first steps toward innovative liquid biopsy applications, results were reported from cell-free DNA samples Bluestar Genomics, a company developing innovative, data-driven, epigenomic approaches to comprehensive disease analysis and diagnostics, today reported research identifying specific epigenomic biomarkers of early pancreatic cancer within c...

Mawi DNA Technologies Launches iSWAB Cell Stabilization Product Line

Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces the launch of iSWAB-Cells. Designed to collect and stabilize intact cells for up to four weeks at room temperature, the sample collection system enables researchers to perform multiple OMICS analyses from the same sample. The iSW...

ARTMS’ QUANTM Irradiation System™ to Be Featured at Two International Conferences in September

ARTMS Products, Inc. announced today that it has been invited to present at the National Nuclear Security Administration’s 2018 Mo-99 Topical Meeting on Tuesday, September 25th and the Third International Symposium on Technetium and other Radiometals in Chemistry and Medicine on Thursday, September 27th. Joel Kumlin will present at the 2018 Mo-9...

Greenlight Guru Hires 25 Year Medical Device Industry Veteran

Brent Atwood to lead new growth as EVP of Sales and Market Strategy INDIANAPOLIS (PRWEB) September 24, 2018 Greenlight Guru, the only quality management software designed specifically for medical device companies, announces former Brooks Life Sciences vice president of global sales and marketing, Brent Atwood, has joined Greenlight Guru as executive vice president of sales and market strategy. ...

Covalon agrees to acquire Cenorin’s AquaGuard division

Under the terms of the agreement, Covalon Technologies will buy all the assets and workforce of AquaGuard business from Cenorin. The Canadian medical technologies company expects that the The post Covalon agrees to acquire Cenorin’s AquaGuard division appeared first on Compelo Medical Devices.

Research Report: How Patients with Addiction Use Digital Health Tools

 Enspektos, LLC, a healthcare innovation consultancy, today released a first-of-its-kind research about how patients with addiction use digital health tools, where voice-enabled technologies are currently being deployed in health and more. Four Q2 2018 digital health trends & themes revealed in the report are: 1. Patients with addiction feel positive about the role digital technologies can ....

Leafbuyer Technologies Announces Letter of Intent to Acquire Leading Mobile Ordering App

Combination Doubles Leafbuyer’s Presence in California Market Leafbuyer Technologies, Inc. (“Leafbuyer”) (OTCQB:LBUY) announced today a non-binding letter of intent to acquire California-based Greenlight Technologies (“Greenlight”). Greenlight provides cannabis consumers real-time mobile ordering and loyalty rewards through a native ap...

Global Bipolar Electrosurgical Devices Market 2018-2022 | 16% CAGR Projection Over the Next Four Years | Technavio

The global bipolar electrosurgical devices market 2018-2022 is expected to post a CAGR of close to 16% during the forecast period, according to the latest market research report by Technavio. This press release features multimedia. View the full release here:

Aerie Pharmaceuticals Announces Appointment of Damien Monaghan, Quality Director

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, today announced the appointment of Damien Monaghan, Quality Director, reporting to Finb...

EDETEK Kicks Off Fall with Two Major Life Sciences Industry Events

Company addressing full data lifecycle with disruptive solutions PRINCETON, N.J. (PRWEB) September 24, 2018 EDETEK, the premier provider of digital clinical trial platforms, today announced that the team will be exhibiting at the Society for Clinical Data Management (SCDM) 2018 Annual Conference taking place in Seattle, WA on September 23-26, 2018. The team will also be participating at DPHARM: D...

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

• First-to-market cell line-derived reference standard for myeloid blood cancers • Largest cell-line derived reference standard available, contains 22 mutations across 19 oncology-relevant genes • Enables faster, more reliable and more cost-effective assay validation Cambridge, UK, 24 September, 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “t...

Sunday 23rd September 2018

DMP 'type 1 diabetes': Institute recommends revision

(Institute for Quality and Efficiency in Health Care) New guidelines change the results of the final report versus the preliminary report: Stronger focus, among other things, on the avoidance of hypoglycaemia by means of modern Technologies.

TransEnterix Acquires Assets, Intellectual Property and Retains R&D Team from MST Medical Surgery Technologies

Adds advanced surgical image analytics technology capabilities to Senhance digital laparoscopy platform Establishes Israel-based R&D Center TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today an...

Namaste Technologies gets first-of-its-kind medical cannabis license from Health Canada

The company said its Cannmart subsidiary received the Access to Cannabis for Medical Purposes Regulations license for 'sales only'

Saturday 22nd September 2018

University of Tokyo to Evaluate AVAX's Breast Cancer Vaccine

AVAX Technologies Inc. (Kansas City, MO) and the University of Tokyo have entered into a collaborative research agreement to evaluate the application of the AVAX's patented AC Vaccine technology for the treatment of breast cancer...

IntelGenx Technologies Aktie: Im Abwärtssog!

IntelGenX Technologies konnte vor Kurzem von der Kursexplosion bei Tilray profitieren. Da die beiden Unternehmen eine Zusammenarbeit für oral zu verabreichende Cannabis-Produkte diskutieren, zog Ti...

Friday 21st September 2018


NEW ORLEANS, Sept. 21, 2018 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., Read more...

ProLon® Celebrates Second Year Anniversary with the Announcement of a New Major Patent and More Than 80,000 Impacted Consumers’ Lives

After only two years, L-Nutra's flagship product, ProLon®, the first-ever five-day Fasting Mimicking Diet® (FMD®), is currently the only product in healthcare that is designed, researched, tested, and now patented for optimizing longevity and healthspan.

Quick Search


News Quicklinks